Results 21 to 30 of about 152,172 (364)
Respiratory infections in children and adolescents in Germany during the COVID-19 pandemic [PDF]
Journal of Health Monitoring, 2023 Background: Before the COVID-19 pandemic, acute respiratory infections (ARIs) in children were mainly characterised by three pathogens: respiratory syncytial viruses (RSV), influenza viruses and rhinoviruses.
Udo Buchholz +7 more
doaj +1 more source
Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
Pathogens, 2023 Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease, especially in young children. Despite its global impact on healthcare, related to its high prevalence and its association with significant morbidity, the ...
D. Gatt +3 more
semanticscholar +1 more source
The path to an RSV vaccine [PDF]
Current Opinion in Virology, 2013 Respiratory syncytial virus (RSV) is the greatest remaining unmet infant vaccine need in developed countries and an important unmet infant vaccine need worldwide. More than 40 years of effort have yet to result in a licensed RSV vaccine for humans.
Christine A. Shaw +7 more
openaire +3 more sources
Journal of Family Medicine and Primary Care, 2021 Background: Acute bronchiolitis is fatal disease involving lower respiratory tract of infants and children of paediatric age group. Respiratory Syncytial Virus (RSV) is responsible for causing more than 70% hospital admissions of children aged less than ...
Charu Singh +5 more
doaj +1 more source
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis
Open Forum Infectious Diseases, 2022 Background Adult respiratory syncytial virus (RSV) vaccines are in the late stages of development. A comprehensive synthesis of adult RSV burden is needed to inform public health decision-making. Methods We performed a systematic review and meta-analysis
J. McLaughlin +5 more
semanticscholar +1 more source
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
Frontiers in Immunology, 2022 Respiratory syncytial virus (RSV) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalizations and a substantial number of outpatient visits, which result in a huge economic and healthcare burden.
S. Esposito +6 more
semanticscholar +1 more source
Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting [PDF]
, 2020 Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in children worldwide and is a significant cause of hospital admissions in young children in England.
Kinyanjui, Timothy +5 more
core +1 more source
Nasal Microbiota in RSV Bronchiolitis [PDF]
Microorganisms, 2020 Respiratory Syncytial Virus (RSV) is the leading cause of bronchiolitis, and the severity may be influenced by the bacterial ecosystem. Our aim was to analyze the nasal microbiota from 48 infants affected by bronchiolitis from RSV virus and 28 infants with bronchiolitis but negative for the virus.
Schippa, Serena +11 more
openaire +5 more sources
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
Nature Communications, 2021 Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection with the most severe disease in the young and elderly.
John-Sebastian Eden +24 more
semanticscholar +1 more source
Journal of Clinical Virology, 2020 Respiratory syncytial virus (RSV) immunoprophylaxis (IP) has been shown to reduce RSV hospitalization rates in high-risk infants; however, it is unclear whether RSV IP is associated with increased risk of non-RSV disease, particularly non-RSV hospitalizations.
Leonard R. Krilov +3 more
openaire +3 more sources